Showing results (31-40 of 428) with videos related to
Sort By:
Pageof 43
Therapeutic Advances in Neurological Disorders|December 26, 2022
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched studyKatrin Pape, Leoni Rolfes, Falk Steffen, et al.Journal of Neuroinflammation|November 27, 2020
Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopyJulia Loos, Samantha Schmaul, Theresa Marie Noll, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2018
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosisNelly Siller, Jens Kuhle, Muthuraman Muthuraman, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2019
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MSSinah Engel, Michaela Friedrich, Muthuraman Muthuraman, et al.Therapeutic Advances in Neurological Disorders|May 7, 2021
Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosisSinah Engel, Maria Protopapa, Falk Steffen, et al.The Journal of Experimental Medicine|March 29, 2020
CNS-localized myeloid cells capture living invading T cells during neuroinflammationBeatrice Wasser, Dirk Luchtman, Julian Löffel, et al.Frontiers in Neurology|March 28, 2019
Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive NeurodegenerationKatharina Birkner, Julia Loos, René Gollan, et al.Journal of Neurology|February 15, 2020
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentationJulia Loos, Steffen Pfeuffer, Katrin Pape, et al.Therapeutic Advances in Neurological Disorders|November 24, 2025
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesionsTobias Brummer, Gabriel Gonzalez-Escamilla, Falk Steffen, et al.European Journal of Neurology|May 23, 2025
Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune EncephalitisJohannes Piepgras, Marlene L Piepgras, Falk Steffen, et al.Pageof 43